John Paulson bought $15M of BHC
director at Bausch Health Companies Inc.. 2,788,608 shares at an average of $5.27, traded Jun 10, 2025, filed Jun 12, 2025.
Score components
- +15RoleDirector
- +25Trade size$14.7M at market
- +3Relative to holdingsHoldings up 11%
- +8Price context48% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001013594-25-000742, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 10, 2025 | POpen-market purchase Common Stock, no par valueindirect: By Managed Funds | +754,134 | $5.05 | $3.8M | 27,193,169 | Jun 12, 2025 |
| Jun 11, 2025 | POpen-market purchase Common Stock, no par valueindirect: By Managed Funds | +1,029,098 | $5.24 | $5.4M | 28,222,267 | Jun 12, 2025 |
| Jun 12, 2025 | POpen-market purchase Common Stock, no par valueindirect: By Managed Funds | +1,005,376 | $5.47 | $5.5M | 29,227,643 | Jun 12, 2025 |
Related signals
Other insiders at Bausch Health Companies Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 56Moderate | BHCbuy Bausch Health Companies Inc. | John Paulson director | $21M 3,564,059 shares | +12% | |
| 0Weak | Bausch Health Companies Inc. | Seana Carson EVP, General Counsel | $3,674 440 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.